Evidence map›Paper›PMID 26259127›Full record

ArticleBiomacromolecules2015

Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells.

Sooneon Bae, Ho-Joon Lee, Jeoung Soo Lee, Ken Webb

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sooneon BaeMicroenvironmental Engineering Laboratory and ‡Drug Design, Development, and Delivery Laboratory, Department of Bioengineering, Clemson University , 301 Rhodes Research Center, Clemson, South Carolina 29634, United States.
Ho-Joon LeeMicroenvironmental Engineering Laboratory and ‡Drug Design, Development, and Delivery Laboratory, Department of Bioengineering, Clemson University , 301 Rhodes Research Center, Clemson, South Carolina 29634, United States.
Jeoung Soo LeeMicroenvironmental Engineering Laboratory and ‡Drug Design, Development, and Delivery Laboratory, Department of Bioengineering, Clemson University , 301 Rhodes Research Center, Clemson, South Carolina 29634, United States.
Ken WebbMicroenvironmental Engineering Laboratory and ‡Drug Design, Development, and Delivery Laboratory, Department of Bioengineering, Clemson University , 301 Rhodes Research Center, Clemson, South Carolina 29634, United States.
Clemson University · US

Funding

Targeted Nano-therapeutics for Neural RegenerationP20GM103444 · NIGMS · CLEMSON UNIVERSITY · PI MARKWALD, ROGER R, VYAVAHARE, NAREN R · 2012 to 2018
$14.9M
UNDERSTANDING AND CONTROLLING TISSUE-SPECIFIC VASCULAR PATTERNINGP20RR021949 · NCRR · CLEMSON UNIVERSITY · PI MARKWALD, ROGER R · 2009 to 2011
$5.2M
NCRR NIH HHS P20 RR021949NIGMS NIH HHS 8P20GM103444-04NIGMS NIH HHS P20 GM103444
6 · The paper itself

Abstract

Scaffold-based delivery of bioactive molecules capable of directing stem cell differentiation is critical to the development of point-of-care cell therapy for orthopedic repair. Dexamethasone-conjugated hyaluronic acid (HA-DXM) was synthesized and combined with hydrolytically degradable, photo-cross-linkable PEG-bis(2-acryloyloxy propanoate) (PEG-bis-AP) to form semi-IPNs. Dexamethasone (DX) release was limited in physiological buffer and substantially increased in the presence of encapsulated human mesenchymal stem cells (hMSCs) or exogenous hyaluronidase, confirming that release occurred primarily by a cell-mediated enzymatic mechanism. hMSCs encapsulated in PEG-bis-AP/HA-DXM semi-IPNs increased osteoblast-specific gene expression, alkaline phosphatase activity, and matrix mineralization, attaining levels that were not significantly different from positive controls consisting of hMSCs in PEG-bis-AP/native HA cultured with DX supplementation in the culture medium. These studies demonstrate that PEG-bis-AP/HA-DXM semi-IPNs can provide cell-mediated release of bioactive free DX that induces hMSC osteogenic differentiation. This approach offers an efficient system for local delivery of osteogenic molecules empowering point of care applications.

Indexed as

Cell DifferentiationCells, ImmobilizedDelayed-Action PreparationsDexamethasoneHumansMesenchymal Stem CellsOsteogenesisDelayed-Action PreparationsDexamethasone

Identifiers

PMID26259127
PMCPMC5352458
OpenAlexW1185454890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.